Viewing Study NCT04040205


Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-01-09 @ 9:54 PM
Study NCT ID: NCT04040205
Status: RECRUITING
Last Update Posted: 2025-07-20
First Post: 2019-07-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Sponsor: Medical College of Wisconsin
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module